Molecular Neurodegeneration

译名:分子神经退行性疾病

SCIEJCR Q1中科院1区

>15

2026

影响因子区间

平台估算

投稿周期

23%

2025

中国作者发文占比

2990 EUR;3190 USD;2590 GBP

费用说明

收费

期刊简介:Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms.

【译文】《分子神经退行性变》是一本开放获取、同行评审的期刊,涵盖了分子和细胞水平上神经退行性研究的各个方面。神经退行性疾病共同指由神经退行性引起的神经系统疾病,包括但不限于阿尔茨海默病、帕金森病、亨廷顿病和朊病毒病。这些疾病通常与老龄化有关,并表现出不同程度的痴呆,随着人类寿命的延长和老龄人口的增加,已成为一个重大的公共卫生问题。近年来,在神经退行性疾病发病机制背后的分子和细胞机制方面的最新进展,使得对疾病机制的深入了解成为可能。

出版社
BioMed Central
语言
English
学科
医学
ISSN
1750-1326
eISSN
1750-1326
出版频率
月刊
创刊年份
2006
投稿网址
https://www.editorialmanager.com/mond
最近更新
2026-04-02 18:16:40
Molecular Neurodegeneration

指标当前值近三年趋势
JCR分区Q1
暂无
中科院分区1区
暂无
影响因子区间>15
暂无